RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgans, Alicia K., Smith, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196262/
https://www.ncbi.nlm.nih.gov/pubmed/22013547
http://dx.doi.org/10.4061/2011/941310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196262/
https://www.ncbi.nlm.nih.gov/pubmed/22013547
http://dx.doi.org/10.4061/2011/941310

Ejemplares similares